The reporter learned from Jointown Pharmaceutical Group Co.Ltd(600998) pharmaceutical group that on March 13, Jointown Pharmaceutical Group Co.Ltd(600998) Pharmaceutical Group announced that it had reached strategic cooperation with Bgi Genomics Co.Ltd(300676) and Beijing huaketai Biotechnology Co., Ltd. respectively, and would vigorously promote the accessibility of covid-19 antigen detection reagent and fully support the epidemic prevention and control in China. Both companies said that their cooperation with Jointown Pharmaceutical Group Co.Ltd(600998) aims to rapidly promote covid-19 antigen test reagent to the whole country Jointown Pharmaceutical Group Co.Ltd(600998) has the advantage of “wholesale and retail integration”, which can help high-quality products and services quickly reach pharmaceutical retail terminals and institutions at all levels in China, and effectively support China’s demand for disease prevention and control Jointown Pharmaceutical Group Co.Ltd(600998) said that in order to help covid-19 test products quickly spread to the whole country, the company is actively contacting a number of covid-19 antigen test reagent manufacturers. The product types will cover all test methods, and more cooperation information will be published in time in the future.
© China Stock Market News